Background and purpose: To minimize the risk of hematogenous periprosthetic joint infection (HPJI), international and Dutch guidelines recommended antibiotic prophylaxis prior to dental procedures. Unclear definitions and contradictory recommendations in these guidelines have led to unnecessary antibioti...
Wedzicha, JA;
Calverley, PMA;
Albert, RK;
Anzueto, A;
Criner, GJ;
Hurst, JR;
Miravitlles, M;
Papi, A;
Rabe, KF;
Rigau, D;
Sliwinski, P;
Tonia, T;
Vestbo, J;
Wilson, KC;
Krishnan, JA.
This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...
Adrenergic beta-2 Receptor Agonists/therapeutic use,
Aminopyridines/therapeutic use,
Benzamides/therapeutic use,
Cyclopropanes/therapeutic use,
Fluoroquinolones/therapeutic use,
Macrolides/therapeutic use,
Muscarinic Antagonists/therapeutic use,
Phosphodiesterase 4 Inhibitors/therapeutic use,
Disease Progression,
Pulmonary Disease, Chronic Obstructive,
Pulmonary Disease, Chronic Obstructive/drug therapy,
Pulmonary Disease, Chronic Obstructive/physiopathology,
Secondary Prevention/standards,
Adrenergic beta-2 Receptor Agonists,
Aminopyridines,
Benzamides,
Cyclopropanes,
Fluoroquinolones,
Macrolides,
Muscarinic Antagonists,
Phosphodiesterase 4 Inhibitors
Torres, A;
Niederman, M. S;
Chastre, J;
Ewig, S;
Fernandez-Vandellos, P;
Hanberger, H;
Kollef, M;
Li Bassi, G;
Luna, C. M;
Martin-Loeches, I;
Paiva, J. A;
Read, R. C;
Rigau, D;
Timsit, J. F;
Welte, T;
Wunderink, R.
The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been conducted and new information has become available. Studi...
This quick guide contains the key recommendations from the national clinical guideline for the treatment of lumbar spinal stenosis. The guideline concerns patients over the age of 65 years with lumbar spinal stenosis and significant self-rated disability....